These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 3018891)
1. Development of vaccines against hepatitis A and hepatitis B. McLean AA Rev Infect Dis; 1986; 8(4):591-8. PubMed ID: 3018891 [TBL] [Abstract][Full Text] [Related]
2. Vaccines to prevent hepatitis B and hepatitis A virus infections. Hadler SC Infect Dis Clin North Am; 1990 Mar; 4(1):29-46. PubMed ID: 2155262 [TBL] [Abstract][Full Text] [Related]
6. Towards a hepatitis A vaccine. A review. Anderson BN; Coulepis AG; Gust ID J Hyg (Lond); 1984 Oct; 93(2):269-76. PubMed ID: 6094664 [No Abstract] [Full Text] [Related]
7. [Prevention of hepatitis A and hepatitis B by vaccination]. Buisson Y; Meyran M Ann Gastroenterol Hepatol (Paris); 1995 Oct; 31(5):306-8; discussion 308-9. PubMed ID: 8572566 [TBL] [Abstract][Full Text] [Related]
9. [The future of viral hepatitis vaccines]. Shdanov VM Z Gesamte Hyg; 1985 Mar; 31(3):134-7. PubMed ID: 2990115 [No Abstract] [Full Text] [Related]
10. Newer directions in vaccine development and utilization. Hilleman MR J Infect Dis; 1985 Mar; 151(3):407-19. PubMed ID: 2982958 [TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers. Midthun K; Ellerbeck E; Gershman K; Calandra G; Krah D; McCaughtry M; Nalin D; Provost P J Infect Dis; 1991 Apr; 163(4):735-9. PubMed ID: 1849160 [TBL] [Abstract][Full Text] [Related]
12. A two dose combined hepatitis A and B vaccine in Chinese youngsters. Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800 [TBL] [Abstract][Full Text] [Related]
13. Vaccines against hepatitis A and B. Zuckerman AJ Baillieres Clin Gastroenterol; 1990 Sep; 4(3):775-88. PubMed ID: 1962731 [No Abstract] [Full Text] [Related]
14. Prevention of hepatitis A and B. Bell S; Watson K Aust Fam Physician; 1997 Aug; 26(8):933-6. PubMed ID: 9267058 [TBL] [Abstract][Full Text] [Related]
15. Development of live, attenuated hepatitis A vaccine (H2-strain). Mao JS Vaccine; 1990 Dec; 8(6):523-4. PubMed ID: 1965075 [TBL] [Abstract][Full Text] [Related]
16. Possible approaches to develop vaccines against hepatitis A. D'Hondt E Vaccine; 1992; 10 Suppl 1():S48-52. PubMed ID: 1335659 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis vaccination among drug users. Quaglio G; Lugoboni F; Mezzelani P; Des Jarlais DC; Lechi A Vaccine; 2006 Apr; 24(15):2702-9. PubMed ID: 16436307 [TBL] [Abstract][Full Text] [Related]
18. Vaccines for the decade of the 1980s and beyond. Hilleman MR S Afr Med J; 1982 May; 61(19):691-8. PubMed ID: 6281926 [TBL] [Abstract][Full Text] [Related]
19. Control of hepatitis A by inactivated vaccines: unanswered questions and unresolved issues. Purcell RH J Hepatol; 1993; 18 Suppl 2():S61-4. PubMed ID: 8182277 [TBL] [Abstract][Full Text] [Related]
20. [Modern achievements in the study of hepatitis A virus and in the development of a vaccine against this infection]. Gendon IuZ Vopr Virusol; 1989; 34(3):261-7. PubMed ID: 2552681 [No Abstract] [Full Text] [Related] [Next] [New Search]